News and Breakthroughs
Find the latest news and discoveries, as well highlights from Lurie Cancer Center’s programs and events through the links below. To learn more about our accomplishments and the people who make them possible, visit the article archive for older news and read our 2020 Year in Review.
Visit our gallery to view a wide range of photos and videos for oncology professionals, cancer patients and families, cancer survivors, caregivers and community members.
Investigators discovered that the loss of the gene SLIT2 in circulating tumor cells regulates metastasis of prostate cancer tumors, according to a Northwestern Medicine study.
A new grant will fund the hiring of 15 new tenure-track faculty, along with tactics to ensure the success of faculty members from underrepresented populations.
A two-drug combination has been shown to improve patient response to treatment in relapsed or refractory acute myeloid leukemia.
Investigators have developed a new imaging technique that increases the detection and identification of proteoforms by four-fold when compared to current methods.
Investigators have identified distinct epigenetic pathways in African American and European American patients diagnosed with multiple myeloma, according to a Northwestern Medicine study.
A Northwestern Medicine study has identified a molecular mechanism that helps regulate the progression of castration-resistant prostate cancer.
After a pediatric cancer diagnosis, chances of infections remain elevated for more than a decade, according to a recent study.
A change in function in a mitochondrial protein is associated with gene expression that may promote the development of cancer, according to a recent Northwestern Medicine Study.
Northwestern has established the Center for Human Immunobiology (CHI), with the goal of bringing together interdisciplinary scientists and clinicians to uncover the molecular mechanisms of the immune system and translating new discoveries into innovative cures for immune-regulated diseases.
A new Northwestern Medicine trial will test whether a telehealth-based intervention that addresses three behavioral risk factors at once can modify cancer patients’ lifestyles to improve their outcomes.
A first-of-its-kind trial, funded by the National Cancer Institute (NCI), a part of the National Institutes of Health, will test whether a telehealth-based intervention that addresses three behavioral risk factors at once (smoking, overeating and lack of physical activity) can modify cancer patients’ lifestyles to improve their outcomes. The trial will recruit 3,000 participants at 11 Northwestern Medicine hospitals.
An inflammatory signaling protein called interleukin-6 has been linked to the progression of acute myeloid leukemia, representing a potential target for future treatments of the disease.
An emerging therapy showed promise in patients with relapsed B-cell lymphoma who are not ideal candidates for stem cell transplants.
A new study has identified a molecular switch, through a protein called CDK9, that plays an early and critical role in the skin stem cell differentiation process.
Northwestern Medicine investigators have discovered novel mechanisms underlying transcription elongation, the process of synthesizing RNA from DNA.
An immune system kinase promotes tumor inflammation and progression, according to a study published in Nature Communications.
The Robert H. Lurie Comprehensive Cancer Center’s SPORE in Prostate Cancer and Polsky Urologic Cancer Institute announce the following awards in support of innovative prostate cancer research.
- Our Cancer Program at Northwestern Memorial Hospital Ranked No. 9 in the Nation by U.S. News & World Report07.27.2022
Lurie Cancer Center at Northwestern Memorial Hospital is ranked No. 9 in the nation by U.S. News & World Report in its 2021-2022 list of Best Hospitals for Cancer, and recognized once again as the top Cancer program in Illinois and Chicago.
An epigenetic inhibitor increased immune system activity in patients with ovarian cancer.
The newly formed Associate Board of Lurie Cancer Center held a cocktail reception on July 14, 2022, at Woodwind restaurant in Chicago. Throughout the year, these dedicated young professionals have raised $115,000 to support cancer research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Investigators have discovered novel cellular pathways behind chemotherapy-resistant glioblastoma cells and a potential biomarker, paving the way for new therapeutic targets.
Northwestern Medicine investigators have discovered novel mechanisms that regulate cellular stress response, according to findings published in the Proceedings of the National Academy of Sciences.
With the mindset and discipline of an engineer, Professor Evan Scott seeks to improve drug therapy efficiency and effectiveness for a wide range of diseases.
Bicarbonate ions are required for cell growth in some cancers, according to a Northwestern Medicine study.
In adult patients undergoing cancer treatment, weekly electronic symptom monitoring significantly improved quality of life, according to a recent study published in JAMA.
Congratulations to Conner Imbody, MPH, Clinical Research Coordinator at Lurie Cancer Center, on the overwhelming success of his 10-week fundraising challenge as a Leukemia & Lymphoma Society (LLS) Man of the Year candidate!
An enzymatic modifier of messenger RNA has different functions depending on its location, according to a recent study.
A new study provides evidence that blood epigenetic biomarkers contain “snapshots” of past cardiovascular health exposures and behavior at the molecular level.
Proteins gain new interactions that are potentially oncogenic and could drive cancer development and growth, according to a recent study.
See more news in the article archive.